Skip to main content
. 2017 Apr 10;8(32):52345–52356. doi: 10.18632/oncotarget.17017

Figure 1. Cisplatin increases ALDH activity in HNSCC.

Figure 1

SCC4 and PCI-13 cells were treated for 2 days with 15 μM cisplatin. ALDH activity was determined using an Aldefluor assay in surviving cells and compared with the non-treated cells to evaluate the effect of cisplatin. The fluorescence intensity (ALDH activity) was determined by flow cytometry. Results represent the means and SEMs of two independent experiments. (* and #p < 0.05 compared to respective controls, t-test).